Literature DB >> 33417005

Head tremor and pain in cervical dystonia.

Jeanne P Vu1, Ha Yeon Lee1, Qiyu Chen1, Elizabeth Cisneros1, Richard L Barbano2, Christopher G Goetz3, Joseph Jankovic4, Hyder A Jinnah5, Joel S Perlmutter6,7, Brian D Berman8, Mark I Appelbaum9, Glenn T Stebbins3, Cynthia L Comella3, David A Peterson10,11.   

Abstract

BACKGROUND: Although head tremor (HT) and pain are prevalent in cervical dystonia (CD), their joint relationship to phenotypic features of focal dystonia remains unclear.
OBJECTIVES: We examined how severity of HT and pain are associated with age of CD onset and duration, and whether HT subtypes ("jerky" or "regular") exhibit distinct relationships between severity of HT and pain.
METHODS: The severity of HT and pain were assessed with the Toronto Western Spasmodic Torticollis Rating Scale in retrospective review of 188 CD patients recruited through the Dystonia Coalition.
RESULTS: HT severity was associated with longer CD duration (p < 0.0005), whereas pain severity was associated with younger age at onset (p = 0.043). HT severity and pain severity were not correlated for jerky HT (p = 0.996), but positively correlated for regular HT (p = 0.01).
CONCLUSIONS: The distinct associations of HT and pain with age at onset, disease duration, and HT subtype further characterize the heterogeneity of CD's clinical presentation and suggest similarly heterogeneous underlying mechanisms.

Entities:  

Keywords:  Cervical dystonia; Dystonic tremor; Head tremor; Pain

Mesh:

Year:  2021        PMID: 33417005      PMCID: PMC8076053          DOI: 10.1007/s00415-020-10378-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Idiopathic cervical dystonia: clinical characteristics.

Authors:  J Chan; M F Brin; S Fahn
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

2.  Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).

Authors:  Joseph Jankovic; Charles H Adler; David Charles; Cynthia Comella; Mark Stacy; Marc Schwartz; Aubrey Manack Adams; Mitchell F Brin
Journal:  J Neurol Sci       Date:  2014-12-27       Impact factor: 3.181

3.  Non-motor features in essential tremor.

Authors:  V Chandran; P K Pal; J Y C Reddy; K Thennarasu; R Yadav; N Shivashankar
Journal:  Acta Neurol Scand       Date:  2011-07-20       Impact factor: 3.209

4.  Clinical and demographic characteristics related to onset site and spread of cervical dystonia.

Authors:  Scott A Norris; H A Jinnah; Alberto J Espay; Christine Klein; Norbert Brüggemann; Richard L Barbano; Irene Andonia C Malaty; Ramon L Rodriguez; Marie Vidailhet; Emmanuel Roze; Stephen G Reich; Brian D Berman; Mark S LeDoux; Sarah Pirio Richardson; Pinky Agarwal; Zoltan Mari; William G Ondo; Ludy C Shih; Susan H Fox; Alfredo Berardelli; Claudia M Testa; Florence Ching-Fen Cheng; Daniel Truong; Fatta B Nahab; Tao Xie; Mark Hallett; Ami R Rosen; Laura J Wright; Joel S Perlmutter
Journal:  Mov Disord       Date:  2016-10-18       Impact factor: 10.338

5.  Quality of life in patients with focal dystonia.

Authors:  Tatjana Pekmezovic; Marina Svetel; Natasa Ivanovic; Natasa Dragasevic; Igor Petrovic; Darija Kisic Tepavcevic; Vladimir S Kostic
Journal:  Clin Neurol Neurosurg       Date:  2008-11-07       Impact factor: 1.876

6.  Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status.

Authors:  Eric S Molho; Nitendra Agarwal; Katy Regan; Donald S Higgins; Stewart A Factor
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

7.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

8.  Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia.

Authors:  I M Skogseid; U F Malt; J Røislien; E Kerty
Journal:  Eur J Neurol       Date:  2007-08-15       Impact factor: 6.089

9.  Pallidal stimulation for primary generalised dystonia: effect on cognition, mood and quality of life.

Authors:  Marjan Jahanshahi; Mariam Torkamani; Mazda Beigi; Leonora Wilkinson; Donna Page; Laura Madeley; Kailash Bhatia; Marwan Hariz; Ludvic Zrinzo; Patricia Limousin; Diane Ruge; Stephen Tisch
Journal:  J Neurol       Date:  2013-11-01       Impact factor: 4.849

10.  Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry.

Authors:  Eric S Molho; Mark Stacy; Patrick Gillard; David Charles; Charles H Adler; Joseph Jankovic; Marc Schwartz; Mitchell F Brin
Journal:  Mov Disord Clin Pract       Date:  2015-12-16
View more
  3 in total

1.  Tourette Syndrome and Driving.

Authors:  Karim Makhoul; Joseph Jankovic
Journal:  Mov Disord Clin Pract       Date:  2021-05-05

2.  Head tremor in cervical dystonia: Quantifying severity with computer vision.

Authors:  Jeanne P Vu; Elizabeth Cisneros; Ha Yeon Lee; Linh Le; Qiyu Chen; Xiaoyan A Guo; Ryin Rouzbehani; Joseph Jankovic; Stewart Factor; Christopher G Goetz; Richard L Barbano; Joel S Perlmutter; Hyder A Jinnah; Sarah Pirio Richardson; Glenn T Stebbins; Rodger Elble; Cynthia L Comella; David A Peterson
Journal:  J Neurol Sci       Date:  2022-01-22       Impact factor: 4.553

3.  Hold that pose: capturing cervical dystonia's head deviation severity from video.

Authors:  Zheng Zhang; Elizabeth Cisneros; Ha Yeon Lee; Jeanne P Vu; Qiyu Chen; Casey N Benadof; Jacob Whitehill; Ryin Rouzbehani; Dominique T Sy; Jeannie S Huang; Terrence J Sejnowski; Joseph Jankovic; Stewart Factor; Christopher G Goetz; Richard L Barbano; Joel S Perlmutter; Hyder A Jinnah; Brian D Berman; Sarah Pirio Richardson; Glenn T Stebbins; Cynthia L Comella; David A Peterson
Journal:  Ann Clin Transl Neurol       Date:  2022-03-25       Impact factor: 5.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.